Fineline Cube

Follow:
14455 Articles
Policy / Regulatory

China’s NHC Launches Health Literacy Plan to Shift Focus to Preventative Healthcare

CompanyDrug

Bristol Myers Squibb’s Breyanzi Shows Promising Results in Three Lymphoma Trials

CompanyDrug

AbelZeta and AstraZeneca’s C-CAR031 Shows Promising Results in HCC Treatment

CompanyDrug

InnoCare’s Tafasitamab-Lenalidomide Combo on Track for Priority Review in China for DLBCL Treatment

CompanyDrug

Jiangsu Hengrui Receives NMPA Approval to Begin Clinical Trials for New Anticancer Biologic

CompanyDeals

Shenzhen Light and Biotechnology Partners with Shenzhen Increcare Biotech in IVD Sector

CompanyDrug

AIM Vaccine Submits Pre-IND Applications for mRNA Vaccines Targeting RSV and Herpes Zoster to NMPA

CompanyDeals

OBiO Technology Partners with Shenzhen Innovation Immunotechnology for TCR-T Cell Therapy Development

CompanyDrug

Olymvax Bio Receives Ethical Approval for Oral Helicobacter pylori Vaccine Trial in Australia

CompanyDrug

Sanofi Receives NMPA Approval for Phase III Clinical Trial of RSV Vaccine SP0125

CompanyDeals

BOE-Backed Genewise Bio Secures RMB 100 Million in Series A Financing for Molecular Diagnostics

CompanyDrug

Huadong Medicine’s ROR1-Targeting ADC HDM2005 Cleared for Clinical Trials by China’s NMPA